Profile
Pattern’s patented PPI-100 activates innate immunity against cancers and infectious diseases. Pattern intends commencing a clinical study in Q1 2026 in perioperative immunotherapy to address the ~40% relapse rate 5 years after cancer surgery. PPI-100 is a GMP version of an earlier product approved in ex-US jurisdictions for use against infectious diseases, where it proved safe & efficacious during widespread use. Pattern collaborates with Massachusetts General Hospital, MD Anderson, University of Toronto and McGill.
Website
patternpharma.comContact
-
Mark de Groot, Chief Executive OfficerTel: +1 416-302-5155Email: mdegroot@patternpharma.com
-
-
-
-
-
-
Event details
Date: November 9 - 11, 2026
Event contact
Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
<?php
global $lang_id;
switch ($lang_id) {
case "fr":
echo 'Total de 24';
break;
case "pt-br":
echo 'Total de 24';
break;
case "es":
echo 'Total de 24';
break;
case "ja":
echo '24 合計';
break;
case "ko":
echo '24 총계';
break;
case "en":
default:
echo '24 in total';
break;
}
?>
-
20/20 OptimEyes Technologies is developing OPT-101, a sustained-release glaucoma eye drop designed to reduce… -
APS Pharma™ is a Canadian innovation-focused specialty chemistry… -
AlloWide Health is an Ontario-based biotechnology company developing innovative solutions to improve the… -
Altis Labs is the AI endpoint company accelerating clinical trials. Altis has trained proprietary… -
Lumerate’s investor intelligence brand, tracks global life science deal flow to reveal behavioral signals that… -
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. BioScript… -
Bough Bio is a pre-clinical stage company focused on decoding the molecular biology of senescent cells to unlock… -
Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets… -
Drug formulation has the power to transform promising compounds into life-saving therapies, yet this step is… -
JN Nova Pharma is a Canadian biotechnology company developing a proprietary platform technology to… -
Over 30% of organ transplant patients have complications due to CMV. Kanata… -
Medicenna Therapeutics is a clinical-stage immunotherapy company engineering next-generation cytokine therapies… -
Pattern’s patented PPI-100 activates innate immunity against cancers…
-
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation… -
Singularity Pharma is a drug discovery business developing novel therapeutics for… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (YYZ) is a deep tech company endeavoring to profoundly progress new medicine for…